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Abstract
Background: Various clinical protocols have been developed to aid in the clinical diagnosis of classical bovine
spongiform encephalopathy (BSE), which is confirmed by postmortem examinations based on vacuolation and
accumulation of disease-associated prion protein (PrP
d) in the brain. The present study investigated the occurrence
and progression of sixty selected clinical signs and behaviour combinations in 513 experimentally exposed cattle
subsequently categorised postmortem as confirmed or unconfirmed BSE cases. Appropriate undosed or saline
inoculated controls were examined similarly and the data analysed to explore the possible occurrence of
BSE-specific clinical expression in animals unconfirmed by postmortem examinations.
Results: Based on the display of selected behavioural, sensory and locomotor changes, 20 (67%) orally dosed and
17 (77%) intracerebrally inoculated pathologically confirmed BSE cases and 21 (13%) orally dosed and 18 (6%)
intracerebrally inoculated but unconfirmed cases were considered clinical BSE suspects. None of 103 controls
showed significant signs and were all negative on diagnostic postmortem examinations. Signs indicative of BSE
suspects, particularly over-reactivity and ataxia, were more frequently displayed in confirmed cases with vacuolar
changes in the brain. The display of several BSE-associated signs over time, including repeated startle responses
and nervousness, was significantly more frequent in confirmed BSE cases compared to controls, but these two
signs were also significantly more frequent in orally dosed cattle unconfirmed by postmortem examinations.
Conclusions: The findings confirm that in experimentally infected cattle clinical abnormalities indicative of BSE are
accompanied by vacuolar changes and PrP
d accumulation in the brainstem. The presence of more frequently
expressed signs in cases with vacuolar changes is consistent with this pathology representing a more advanced
stage of disease. That BSE-like signs or sign combinations occur in inoculated animals that were not confirmed as
BSE cases by postmortem examinations requires further study to investigate the potential causal relationship with
prion disease.
Background
Classical BSE is a prion disease of domesticated cattle
presenting as a slowly progressive neurological disorder
[1]. Signs associated with BSE, which comprise abnorm-
alities of behaviour, sensation and locomotion, have
been assessed as part of the passive surveillance in the
UK to define the clinical phenotype of BSE [2,3]. Based
on more detailed examinations and observations of BSE
field cases, specific clinical protocols have been devel-
oped to aid in the clinical diagnosis of BSE field suspects
[4-6] and to monitor clinical onset and progression in
cattle experimentally challenged with BSE [7].
The confirmatory diagnosis of BSE was initially reliant
on detection of vacuolar changes or scrapie-associated
fibrils in the brain [1]. It was shown that in clinically
suspect cases lesions occurred consistently in the brain-
stem and that examination of the medulla oblongata
provided the greatest sensitivity of the histopathological
diagnosis [8]. Correlation of the histopathological
changes, visualisation of fibrils and the detection of the
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(PrP
Sc) by Western blotting, dot and histo-blotting con-
firmed the suitability of sampling the medulla for diag-
nosis [9,10]. In the past decade refinements in the
regulatory diagnosis have fully implemented disease-
specific immunological methods including IHC, for
detection of the disease-associated prion protein, PrP
d,
in tissue sections without the use of protease enzymes
and WB and ELISA tests, which detect proteinase K
resistant prion protein, PrP
res [11,12].
The currently used postmortem tests can diagnose a
TSE in the preclinical stage, before the animal displays
evident signs of a neurological dysfunction, and this has
been shown in experimentally induced BSE, where the
term “definite signs” has been used to denote clearly
progressive neurological disease [13]. Earlier changes,
mostly behavioural, may be present [14] but due to their
unspecific nature may overlap with the range of expres-
sions of normal animal behaviour.
In contrast to field cases of BSE where the time of expo-
sure to the causative agent via contaminated MBM is not
known and BSE-like signs can be due to various other dis-
eases [15], experimental challenges with the BSE agent
offer the opportunity for regular clinical monitoring of
animals under controlled conditions, enabling detailed
documentation of clinical signs and subsequent correlation
with the results of confirmatory diagnostic tests.
This study investigates whether clinical signs asso-
ciated with BSE (based on certain selected test responses
or their combinations) are specific for pathologically
confirmed cases of experimental BSE in cattle and can
be displayed in the absence of detectable vacuolation,
PrP
d or PrP
res in the brainstem by currently applied
diagnostic postmortem examinations.
Methods
All procedures were carried out in accordance with the
Animal (Scientific Procedures) Act 1986, under licence
from the UK Government Home Office.
Animal data sources
The data used in this study were derived from the mon-
itoring of cattle from two previously reported experi-
ments which examined the transmissibility of BSE
[13,16]. In study 1 [13], 200 Friesian cattle were dosed
orally; 90 castrated males and ten female cattle with
100 g and 90 castrated male and ten female cattle with
1 g of titred BSE-affected brainstem homogenate. One
hundred Friesian undosed cattle (90 castrated male and
ten female cattle) served as controls. All cattle were pur-
chased from UK farms with no history of BSE at the
time of sourcing. (Subsequently, three BSE cases from
two source farms were detected as part of the BSE
surveillance; one of these was sold off to another farm.
These cases were born between 1992 and 1994, whereas
12 cattle from these farms that were used for the project
were born in 1998). Each group was housed separately.
Heifers were artificially inseminated to produce calves
and enable sequential milk collections. Steers were sub-
ject to regular sampling of blood and cerebrospinal fluid
for archiving purposes and were culled by random allo-
cation to a sequential kill protocol: six challenged and
three age-matched control cattle were killed at three-
monthly intervals after dosing, increasing to six-monthly
intervals after dosing subsequent to the first year in the
case of the 1 g dose group. Female cattle were kept
until development of unequivocal signs of a neurological
disease consistent with BSE or signs of any other
untreatable or welfare compromising disease; surviving
dosed cows were culled at 88 mpi together with age-
matched control cows.
Data from 291 cattle was used for the analysis;
excluded animals were predominantly controls culled
early in the course of the experiment. The diagnostic
outcome of cattle from this study has been reported
previously [13] and further information on individual
animals published elsewhere [17].
In study 2 [16], 63 groups of five Friesian or Friesian
crossbred castrated male calves from UK farms with no
history of BSE at the time of sourcing were inoculated
intracerebrally. (Seven BSE cases from four source farms
were detected subsequently as part of the BSE surveil-
lance; five of these were sold off and one was purchased.
These cases were born between 1987 and 1994, whereas
the earliest birth year of 65 cattle that were sourced
from these farms for the project was 1996). Each of 62
groups received a different pool of tissues or body fluids
(1 ml of a 10% homogenate in saline solution) obtained
from calves dosed orally with 100 g of titred BSE-
affected brainstem homogenate and culled at various
time points during the incubation period [16,18]. The
remaining group received a pooled inoculum of nictitat-
ing membrane from naturally infected BSE cases [19].
Two groups of Friesian or Friesian crossbred male
castrated cattle inoculated with saline solution served as
controls. The groups were kept separately. Cattle were
retained for seven years post inoculation or culled when
they developed BSE signs or other untreatable or welfare
compromising disease. Data from all cattle of study 2
were analysed. The diagnostic status of individual cattle
at the termination of this study ([20]; SAC Hawkins and
GAH Wells, unpublished data), differed from that in the
published interim report of the experiment [16] in only
the outcome of an additional tissue inoculation with 1/5
cattle positive that were inoculated with a pool of nicti-
tating membrane from natural cases of BSE.
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Clinical signs are defined as behavioural or other signs
that are observed irrespective of an underlying patholo-
gical condition. Some signs may - to an extent - also be
displayed by healthy animals, such as nose licking or
over-reactivity to external stimuli. The clinical assess-
ments in this study comprised neurological examina-
tions and behavioural observations.
Neurological examinations
Neurological examinations were carried out every three
months from 12 mpi according to a standard protocol [7].
Pre-cull examinations were generally carried out in the
week prior to euthanasia of the animals. Tests of over-
reactivity were used to assess responses to external stimuli
and included the stick test, the flash test, clipboard test
and bang test or hand clap as previously described [5].
Behavioural observations
Regular, usually weekly, passive observations of cattle in
their pens were carried out by trained scientific staff or
veterinarians. The observation time was dependent on the
group size, calculated as 3 minutes multiplied by the num-
ber of animals in the group, but was usually 15 minutes,
even for groups of less than five animals. A standard form
was used to record behaviours associated with BSE [7].
As far as was possible all assessments were made
without the observer having prior knowledge of the
inoculation status of the cattle.
Animal husbandry
Cattle were housed in medium security accommodation
at two facilities: VLA Weybridge and ADAS Drayton.
The latter housed all cattle in study 1 and 47 groups of
cattle in study 2. These cattle were usually transported
to Weybridge prior to euthanasia and a pre-cull exami-
nation was conducted at least one day after transport so
that they could acclimatise to the new environment. All
cattle were given straw or hay ad libitum and all
received a daily concentrate ration free from MBM. The
amount of hay or straw and concentrate ration varied
according to growth of the cattle and their decreasing
energy demand with increasing age to avoid excessive
obesity, particularly in steers. Similarly, individual cattle
within a group received food supplement if their weight
or body condition score decreased considerably com-
pared to the rest of their group. Cows, which were used
for milk production, were fed according to their energy
requirements during lactation and dry period. This
resulted in fluctuation of the weight and body condition
of cattle and made assessment of these signs too unreli-
able to be used for the analysis.
Postmortem diagnosis
The tests used for BSE diagnosis have been described
elsewhere [13,21] and included those used for the
statutory confirmation of BSE in the UK surveillance
programme. Sections of the medulla at the obex were
stained with haematoxylin and eosin for HP and immu-
nolabelled with antibody R145 for detection of PrP
d by
IHC. WB used the “VLA Hybrid” technique [22], and an
ELISA method (BioRad TeSeE [13]) was used on fresh
samples of the caudal medulla adjacent to the obex to
detect PrP
res.
Further sections of brainstem from all cattle in study
1, representing rostral medulla oblongata and mesence-
phalon, immunolabelled with antibody R145, were
examined in a previous study [23]. In addition to further
brainstem sections, cerebellum, thalamus, corpus stria-
tum and cerebral cortex were similarly examined from
all cattle in study 2 as described previously for selected
cases [21].
Analysis
Clinical signs
The clinical signs that were evaluated and their corre-
sponding definitions are displayed in the Additional file
1: Assessed signs. These included 27 signs assessed by
clinical examinations and 33 signs assessed on beha-
vioural observations. Behavioural observations were pas-
sive and were conducted more frequently than clinical
examinations, which included active stimulation of the
animals. The two approaches were compared separately,
even if some of the assessed signs were identical. The
selection of clinical signs was based on published
descriptions of signs in natural cases of BSE in cattle
[3,24,25]. Not all signs could be assessed in all cattle
for various reasons. For example, recognition of the
significance of certain clinical tests resulted in their sub-
sequent application during the study (e.g. tests of over-
reactivity). Also signs like “nervous entering the milking
parlour” were only assessed in study 1; the milking par-
lour being available only in that study and used simply
to evaluate the behaviour of steers in an unfamiliar
environment.
All signs were considered to be independent although
some combinations of signs were also considered. For
example, as the assessment of over-reactivity to external
stimuli has been particularly useful in the clinical diag-
nosis of suspect BSE cases [5,24], the responses to hand
clap or bang test, flash test, clipboard test, stick test
were combined as tests of over-reactivity. In addition,
t h es i n g l ea b n o r m a lr e s p o n s et os u d d e nn o i s e ,f l a s h
light and the clipboard and the single occurrence of
startle responses in general was assessed separately from
repeated (more than twice) events.
As the reliable clinical diagnosis of BSE has been
made when cattle display evident signs in at least two of
the three categories: changes in behaviour, sensation
and locomotion [24], selected signs in these categories,
Konold et al. BMC Veterinary Research 2010, 6:53
http://www.biomedcentral.com/1746-6148/6/53
Page 3 of 13noted at the pre-cull examination and the last three
observation periods prior to cull, were assessed. Criteria
for the suspect diagnosis of BSE were the combined dis-
play of at least one of the signs in two of the following
three categories:
￿ Behavioural changes: nervousness or apprehension in
the corridor (during the clinical examination) or appre-
hension (during the observation period).
￿ Sensory changes: Abnormal stick test, repeated
(more than twice) over-reactivity to external stimuli
(clipboard test, flash test, test to over-reactivity to
sound) or spontaneous repeated startle responses (dur-
ing the examination) or spontaneous startle responses,
flinch on approach by hand, repeatedly in one observa-
tion period or once each in least two observation
periods.
￿ Locomotor changes: Ataxia or hypermetria.
Statistical analysis
Grouping of animals for analysis according to source
study, experimental treatments and the total number of
assessments (examinations and observations) throughout
the study are given in Table 1. Groupings were accord-
ing to the postmortem BSE diagnosis, with subgroupings
depending on the inoculation dose (study 1) or tissue
type inoculated (study 2). For comparison, animals of
study 1 were grouped into undosed controls, BSE-nega-
tive challenged cattle and BSE-positive challenged cattle.
In addition, as confirmed BSE cases were culled at
different disease stages, cases with a positive IHC post-
mortem result (presence of PrP
d) were further divided
into those with evident vacuolar changes and those with
no or only minimal vacuolar changes at the obex (not
shown in Table 1). Animals in study 2 were grouped
into control cattle (group 1), those negative on postmor-
tem test diagnosis that were inoculated with tissues that
were not expected to be infectious because of published
information on tissue infectivity relative to incubation
period in BSE pathogenesis (group 2), those negative on
postmortem test diagnosis but with expected infectivity
either because infectivity has been previously demon-
strated in the donor tissue [23,26-28] or other animals
in the group were positive for BSE on postmortem test
diagnosis (group 3) and cattle positive on postmortem
test diagnosis that were inoculated with tissues with
confirmed infectivity (group 4). The grouping was
made under the assumption that the clinical presenta-
tion would be independent of the inoculated tissue
that produced the disease because BSE in cattle inocu-
lated with distal ileum, tonsil or CNS appeared to be
clinically similar (T Konold, unpublished observation).
The study 2 groups were made up as follows:
Group 1 (control): cattle inoculated with saline
solution.
Group 2: cattle inoculated with urine, kidney, skin,
bone marrow, buffy coat, cervical/popliteal lymph nodes,
mesenteric lymph node, thymus, spleen, liver, salivary
glands, peripheral nerve, skeletal muscle, spinal cord,
Table 1 Grouping of animals according to source study, experimental treatments, postmortem diagnosis, the total
number of assessments (examinations and observations) and the number (%) clinically diagnosed on the basis of
selected criteria prior to cull
Group (N animals) Postmortem
BSE diagnosis
Total
examinations
Total
observations
Number (%) of
cattle with a clinical
diagnosis of BSE
Study 1 (oral challenge)
Controls, not dosed (93) Negative 982 8 473 0 (0)
100 g BSE brainstem (25) Positive 318 2 338 17 (68)
1 g BSE brainstem (5) Positive 96 923 3 (60)
100 g BSE brainstem (74) Negative 365 2 139 11 (15)
1 g BSE brainstem (94) Negative 1 076 9 205 10 (11)
Study 2 (intracerebral inoculation)
Group 1: Control (10) Negative 193 2 556 0 (0)
Group 2: Tissue without expected infectivity (240) Negative 5 290 59 310 15 (6)*
Group 3: Tissue with expected infectivity (53) Negative 1 204 12 526 3 (6)*
Group 4: Tissue with confirmed infectivity (22) Positive 110 1 051 17 (77)
Total 9 634 98 521
Study 1: cattle culled at pre-determined time points post dosing.
Study 2: cattle culled upon development of BSE or at 7 years post inoculation; see Methods for groupings.
* Clinical suspects despite negative postmortem BSE diagnoses were: in group 2 (n = 15) inoculated with pooled kidney (collected at 18 mpi), mesenteric lymph
node (18 mpi), bone marrow (36 mpi), buffy coat (18 mpi), buffy coat (26 mpi; n = 2), CNS and spinal cord C2-3 & T10-11 (18 mpi; n = 2), cervical/popliteal
lymph nodes (26 mpi), peripheral nerve (26 mpi), pooled liver (32 mpi), salivary gland (18 mpi), skin (18 mpi), spleen (18 mpi) and urine (18 mpi) [16], and
in group 3 (n = 3) inoculated with distal ileum (collected at 26 mpi), tonsil (6 mpi) and caudal medulla/spinal cord (26 mpi).
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orally BSE challenged cattle collected at various times
post inoculation [16].
Group 3: cattle inoculated with tonsil [collected at 6,
10 (n = 4), 18, 26 mpi], distal ileum (collected at 26 and
32 mpi), caudal medulla (26 mpi), caudal medulla/spinal
cord pool (26 mpi), spinal cord (26 mpi), peripheral
nerve (32 mpi), nictitating membrane [n = 4 (receiving a
pool of nictitating membrane from BSE field cases)].
Group 4: cattle inoculated with nictitating membrane
(n = 1 [20], receiving a pool of nictitating membrane
from BSE field cases), tonsil (n = 1, 10 mpi), distal
ileum (6, 10, 18 mpi), caudal medulla/spinal cord pool
(32 mpi).
The number of assessments (examinations and obser-
vations) per group are given in Table 1.
The Fisher’s exact test (GraphPad Prism for Windows
version 5. GraphPad Software, San Diego, USA) was
used to compare clinical signs displayed at the last
examination prior to cull. For behavioural observations,
the last three observation periods prior to cull were
taken into consideration to determine absence or pre-
sence of a sign. The null hypothesis was that clinical
signs between controls and BSE-positive cattle and
between controls and BSE-negative cattle inoculated
with BSE brainstem homogenate or with tissue from
BSE-challenged cattle are similar. The Fisher’s exact test
was also used to compare signs at pre-cull examinations
between orally dosed BSE cases with and without vacuo-
lar changes at the obex to test the null hypothesis that
clinical signs in BSE cases with PrP
d and vacuolation in
the brain are similar to BSE cases that have PrP
d but
minimal/no vacuolation in the brain. The null hypoth-
esis was rejected if P<0.05 for a particular sign asso-
ciated with BSE.
Survival analysis [29] was used to test the null hypoth-
esis that the frequencies of occurrence of clinical signs
between controls and BSE-positive cattle and between
controls and BSE-negative cattle inoculated with
BSE brainstem homogenate or with tissue from BSE-
challenged cattle are similar. The failure event was the
observation of a particular sign in an animal and the
survival time was measured from challenge to the first
occurrence and between subsequent occurrences. It was
assumed that a particular sign, if it was caused by BSE,
should be displayed consistently at subsequent assess-
ments. Statistical software (Stata/IC 10.0 for Windows,
2007. StatCorp LP, College Station, USA) was used to fit
Cox proportional hazards models with multiple failures.
Robust standard errors were specified to allow for the
clustering by animal and the Efron method was used for
handling ties in the calculation of the partial likelihood.
When the Wald chi square test for the model indicated
overall differences among the treatment groups of
animals, specific contrasts were tested using further
Wald tests. The significance level of the P-value was
corrected for multiple comparisons (0.05/k where k
equals the number of comparisons). The null hypothesis
was rejected if P<0.0125 (study 1: comparison of BSE-
positive cattle dosed with 100 g, BSE-positive cattle
dosed with 1 g, BSE-negative cattle dosed with 100 g
and BSE-negative cattle dosed with 1 g of BSE brain-
stem with control cattle) and P<0.0167 (study 2: com-
parison of group 4 cattle, group 3 cattle and group 2
cattle with group 1 control cattle) for a particular sign
associated with BSE.
Results
Postmortem diagnosis
Of the postmortem tests used for BSE diagnosis [13,21],
IHC for PrP
d with antibody R145 on sections of the
medulla at the obex was, as previously indicated, the
most sensitive confirmatory method [23]. Previously
examined additional immunolabelled sections of brain-
stem (study 1) [23], or the additional immunolabelled
sections of brainstem and rostral brain regions from all
cattle in study 2, did not alter the diagnosis based solely
on examination of medulla at the obex. Furthermore,
examination of additional brain regions did not provide
evidence of other neurological disease that might have
accounted for clinical signs.
Suspect BSE cases based on signs displayed on pre-cull
examinations
The number of cattle, according to study and experi-
mental group, that at the last examination prior to cull
displayed signs associated with BSE in at least two of
the categories “behavioural changes”, “sensory changes”
and “locomotor changes” is given in Table 1.
Examples of the signs observed in two cattle of study
2 are presented as Additional file 2: CN1150 (suspect-
BSE positive), a confirmed BSE case that displayed beha-
vioural, sensory and locomotor changes, and Additional
file 3: CP1503 (suspect-BSE negative), an unconfirmed
BSE suspect that displayed behavioural and locomotor
abnormalities.
Clinical signs assessed by examinations and observations
prior to cull
Table 2 compares the clinical signs at the last examina-
tion prior to cull in BSE cases from study 1 confirmed on
detection of PrP
d at the obex according to the occurrence
of vacuolar changes. Clinical signs were generally more
frequently recorded in cases with vacuolar changes at the
obex, which was statistically significant for six signs or
sign combinations. See Additional file 4: 143 (BSE posi-
tive-IHC) and Additional file 5: 139 (BSE positive-HP) to
compare the severity of displayed clinical signs between
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vacuolar changes in the medulla at the obex.
The clinical signs in all cattle from both source studies
grouped according to diagnosis and dose or inoculum
are given in Table 3 (signs at the last examination prior
to cull) and Table 4 (signs at the last three observation
periods prior to cull). There was generally a significant
difference in the clinical signs expressed by BSE-positive
animals compared to controls, with signs usually
expressed more frequently in BSE-positive cattle. With
eight exceptions, the frequency of expressed signs
between controls and inoculated BSE-negative animals
did not differ significantly. Exceptions were less frequent
in controls but for refusal to approach or cross an
obstacle, which was more frequent in controls than
BSE-negative, inoculated cattle in study 2. See Addi-
tional file 6: 10 (control) and Additional file 7: 138 (BSE
negative-HP&IHC) as example of the nervous behaviour
and startle responses that were comparatively less fre-
quently exhibited in BSE-free controls (e.g. animal 10)
than BSE-infected cattle that were not confirmed by
postmortem tests (e.g. animal 138).
Signs assessed by clinical examinations that yielded no
significant differences between any of the groups were
“nervous on head restraint”, “last animal in crush”, “ner-
vous on neck prick”, “nervous or head shy in crush”,
“teeth grinding” and “vocal when free”. Signs assessed by
weekly observations with a similar outcome were “stand-
ing idle & not approached”, “head rubbing”, “flank licking”,
“nose wrinkling”, “teeth grinding”, “tremor”, “muscle
Table 2 Signs at the pre-cull examination in BSE cases confirmed on postmortem diagnosis in study 1 and grouped by
the occurrence/severity of vacuolar changes in the brainstem
Vacuolation (N = 21) No or minimal vacuolation (N = 9) P value
Present/N
a (%) Present/N
a (%)
Behaviour
Nervous or apprehensive in corridor 15/21 (71.4%) 5/9 (55.6%) 0.431
Nervous or head shy in crush 11/21 (52.4%) 2/9 (22.2%) 0.229
Crush refused or entered reluctantly 5/21 (23.8%) 2/9 (22.2%) 1.000
Obstacle refused or not approached 3/18 (16.7%) 1/9 (11.1%) 1.000
Kicked out - free 3/21 (14.3%) 0/9 (0%) 0.535
Yawning 3/21 (14.3%) 1/9 (11.1%) 1.000
Vocal - free 1/21 (4.8%) 1/9 (11.1%) 0.517
Teeth grinding 1/21 (4.8%) 0/9 (0%) 1.000
Sensation
Clipboard test abnormal ≥1 14/18 (77.8%) 1/6 (16.7%) 0.015**
Over-reactivity to sound ≥1 14/21 (66.7%) 2/9 (22.2%) 0.046*
Flinch/startle free once 13/21 (61.9%) 3/9 (33.3%) 0.236
Tests of over-reactivity abnormal once/2 tests 13/21 (61.9%) 1/9 (11.1%) 0.017**
Flinch or startle free more than once 12/21 (57.1%) 2/9 (22.2%) 0.118
Head tests - nervous 12/21 (57.1%) 0/9 (0%) 0.004***
Clipboard test abnormal >2 9/18 (50.0%) 0/6 (0%) 0.052
Flash test abnormal ≥1 10/20 (50.0%) 0/8 (0%) 0.025*
Tests of over-reactivity abnormal x3/2 tests 8/21 (38.1%) 0/9 (0%) 0.067
Head restraint - nervous 1/21 (4.8%) 0/9 (0%) 1.000
Over-reactivity to sound >2 7/21 (33.3%) 2/9 (22.2%) 0.681
Exaggerated menace response 5/16 (31.3%) 0/9 (0%) 0.286
Flash test abnormal >2 4/20 (20.0%) 0/8 (0%) 0.295
Neck prick - nervous 8/21 (38.1%) 0/9 (0%) 1.000
Stick test abnormal 0/21 (0%) 0/9 (0%) 1.000
Movement
Ataxia or hypermetria 14/20 (70.0%) 2/9 (22.2%) 0.041*
Tremor 15/21 (71.4%) 4/9 (44.4%) 0.225
a The total number of animals varied because not all signs were assessed in all animals. Excluded are the signs “last in crush” and “nervous entering the milking
parlour” because of the limited assessment of this sign in one or both groups.
P values are expressed quantitatively; values below 0.05 were considered significant and marked * (P = 0.02-0.05), ** (P = 0.01-0.02) or *** (P = 0-0.01).
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others”, “head toss with snort”, “BSE series of events”,
“yawning”, “coughing”, “butting others” and “being
butted”, “mounting others” and “being mounted”, “scratch-
ing” and “tongue playing or rolling”.
There were also no significant differences for any of
the signs assessed by observations between controls
(group 1) and BSE-negative cattle inoculated with var-
ious tissues associated with or without infectivity
(groups 2 and 3) in study 2.
Clinical signs assessed by examinations and observations
over time
Signs that were significantly differently expressed com-
pared to control cattle are given in Table 5 (signs
assessed by examinations) and table 6 (signs assessed by
observations). No significant differences were found for
the signs “last animal in crush”, “obstacle refused or not
approached”, “exaggerated menace response” or “teeth
grinding”, which were assessed by examinations, and
“yawning”, “flehmen”, “teeth grinding”, “head toss with
snort”, “being butted”, “butting others”, “scratching” or
“tongue playing/rolling”, assessed by observations. For
Table 3 Relative frequency of clinical signs expressed at
the pre-cull examination compared to control cattle
Study 11 12 2 2
Groups 1 g &
100 g
1 g 100 g 4 3 2
Postmortem BSE
diagnosis
Pos Neg Neg Pos Neg Neg
Behaviour
Crush refused or entered
reluctantly
↑↑↑ ↑↑↑
Nervous or apprehensive in
corridor
↑↑↑ ↑↑ ↑↑
Obstacle refused or not
approached
↑↓ ↓ ↓ ↓
Nervous entering milking
parlour
↑ —— —
Yawning ↑
Kicked out during
examination
↑
Sensation
Startle repeatedly during
examination
↑↑↑ ↑↑↑ ↑↑↑
Startle once during
examination
↑↑↑ ↑
Clipboard test abnormal
once
↑↑↑
Clipboard test abnormal >2 ↑↑↑
Over-reactivity to sound ≥1 ↑↑↑
Over-reactivity present
once/2 tests
↑↑↑
Over-reactivity present >2/2
tests
↑↑↑
Over-reactivity to sound >2 ↑↑
Flash test abnormal ≥1 ↑
Flash test abnormal >2 ↑
Exaggerated menace ↑
Head tests nervous ↑↑
Stick test: kicking ↑
Movement
Tremor ↑↑↑ ↑
Ataxia or hypermetria ↑↑↑
Groups were compared with undosed controls (study 1) or saline-inoculated
controls (study 2). The BSE-positive animals dosed with 1 g and 100 g in
study 1 were combined to increase the sample size.
(↑) increased frequency of sign; (↓) decreased frequency of sign compared to
control cattle, with P<0.001 (three arrows), P = 0.001-0.01 (two arrows) and
P>0.01 and <0.05 (one arrow). Blank cell: not significant (P>0.05) or no P-value
given because of absence of this sign in both groups.
Only signs that were significantly differently displayed compared to controls
are listed.
Table 4 Relative frequency of clinical signs expressed at
the last three observation periods prior to cull compared
to control cattle
Study 1 1 2
Groups 1 g & 100 g 1 g 4
Postmortem BSE diagnosis Pos Neg Pos
Behaviour
Apprehension ↑↑↑ ↑↑
Unusual asymmetrical ear movements ↑↑↑ ↑
Grooming self ↑↑ ↑
Nose licking ↑
Snorting ↑
Sneezing ↑
Head toss ↑
Sensation
Hyperaesthesia ↑↑↑ ↑ ↑
Abnormal hand approach/clipboard test ↑↑↑ ↑
Startle at movement ↑↑↑
Startle at movement incl. hand approach/
clipboard test
↑↑↑ ↑ ↑
Startle at noise ↑
Posture
Abnormal head carriage ↑
Groups were compared with undosed controls (study 1) or saline-inoculated
controls (study 2). The BSE-positive animals dosed with 1 g and 100 g in
study 1 were combined to increase the sample size.
An arrow (↑) indicates that the sign or sign combination is more frequent
than in control cattle, with P<0.001 (↑↑↑), P = 0.001-0.01 (↑↑)a n dP>0.01 and
<0.05 (↑). Blank cell: not significant (P>0.05) or no P-value given because of
absence of this sign in both groups.
Only signs that were significantly differently displayed compared to controls
are listed. Not shown are the comparisons of signs between controls and BSE-
negative cattle dosed with 100 g of BSE brainstem (study 1) and between
controls and BSE-negative cattle in groups 2 and 3 (study 2) because there
was no significant difference for any of the signs.
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was too low to calculate a P-value because the sign was
rarely expressed, such as “nervousness during head
restraint or during head tests” in cattle of study 1. If sig-
nificant differences were found between controls and
other groups, the hazard rate, i.e. the frequency of a
sign displayed over a time interval, and the total number
of signs were generally greater in animals with con-
firmed BSE than BSE-negative, inoculated animals. Signs
with a significantly lower hazard rate compared to con-
trols were predominantly displayed by BSE-negative,
inoculated animals and mainly comprised signs assessed
by observations.
Discussion
BSE is characterised by a combination of changes in
behaviour, sensation and movement, although the con-
tributory signs that define these categories can be vari-
able [3,30]. It has been shown that BSE should be
considered in cattle that display a combination of appre-
hension, over-reactivity (to touch or sound) and ataxia,
since at least one of these signs featured in 97% of
17,154 cases [3]. Because of the experimental designs of
the two source studies in the present investigation these
criteria are not applicable to the entire population of
animals studied. For example, using the approach for at
least two of the signs apprehension or nervousness,
over-reactivity (as evaluated by tests of over-reactivity
including repeated spontaneous startle responses) and
ataxia or hypermetria, not all experimentally inoculated,
BSE-confirmed cattle were clinical suspects under these
criteria. This was to be expected in study 1 where
animals were culled at pre-defined time points post
c h a l l e n g ea n dt h e r e f o r es o m ec a t t l ew e r ei nt h ee a r l y
stages of disease, or not infected, and thus would not
necessarily display the full spectrum or any of the signs
associated with BSE. In contrast, the cattle in study 2
were culled at clinical end-point when the signs were
convincing enough to suspect BSE, unless, in some
cases, concerns for staff and animal health and welfare
due to the animal’s behaviour precluded monitoring
further progression of signs, such as ataxia. The selec-
tion of criteria to define a clinical suspect as part of this
investigation may explain why some BSE-positive cases
were not identified as clinical suspects: for example, one
BSE case inoculated with distal ileum from orally dosed
cattle culled at 10 mpi developed only over-reactivity
(marked aversion to touch in combination with frequent
startle reaction), which was convincing enough to sus-
pect BSE, although neither nervousness nor ataxia were
displayed.
Conversely, 17 cattle of study 2 that were inoculated
with tissue from BSE-infected cattle were not confirmed
to have BSE based on postmortem tests and no alterna-
tive diagnosis was established but they did display the
sign combination for a clinical BSE suspect. While it is
possible that other conditions affecting the CNS or
other organ systems might cause behavioural, sensory or
locomotor abnormalities, which in combination are
Table 5 Relative frequency of clinical signs at
neurological examinations over time post inoculation
compared to control cattle
Study 1 1 1 1 2 2
Groups 1 g 100 g 1 g 100 g 4 2
Postmortem BSE diagnosis Pos Pos Neg Neg Pos Neg
Behaviour
Nervous or apprehensive in
corridor
↑↑↑ ↑↑↑ ↑↑↑ ↑↑↑
Nervous entering milking
parlour
↑↑↑ ↑↑↑ ——
Kicked out during examination ↑↑ ↑↑ LI LI LI
Nervous/head shy in crush ↑ ↑↑↑ ↑↑↑
Vocal free ↑↑↑
Crush refused or entered
reluctantly
LI LI LI LI ↑
Yawning ↑↑↑
Sensation
Startle during examination
once
↑↑↑ ↑↑↑ ↑↑↑ ↑↑↑
Startle during examination
repeatedly
↑↑↑ ↑↑↑ ↑↑ ↑↑↑ ↑↑↑
Clipboard test abnormal ≥1 ↑↑↑ ↑↑↑ ↑↑
Clipboard test abnormal >2 ↑↑↑ ↑↑↑
Over-reactivity to sound once ↑↑↑ ↑↑↑
Over-reactivity present once/2
tests
↑↑↑ ↑↑ ↑↑
Over-reactivity present >2/2
tests
↑↑↑ ↑↑↑
Over-reactivity to sound >2 ↑↑↑ ↑↑
Flash test abnormal >2 ↑↑↑ LI
Flash test abnormal ≥1 ↑↑↑ ↓
Stick test: kicking LI LI LI LI ↑↑↑
Head tests nervous LI LI LI LI ↑↑
Head restraint nervous LI LI LI LI ↓
Movement
Tremor ↑↑ ↑↑↑ ↑↑ ↑↑↑
Ataxia or hypermetria ↑↑ ↑↑↑ ↑↑↑
Groups were compared with undosed controls (study 1) or saline-inoculated
controls (study 2).
↑=g r e a t e r / ↓ = lower hazard rate than controls, with P<0.001 (three arrows), P =
0.001-0.01 (two arrows) and P>0.01 and <0.0125 (four comparisons) or <0.0167
(three comparisons) (one arrow). Blank cell: no significant difference; low
incidence (LI): signs too rare in at least one of the groups to calculate a P-value.
Only signs that were significantly differently displayed compared to controls are
listed. Groups are omitted if none of the signs were significantly different
compared to controls.
Not shown is the comparison of signs between controls and cattle inoculated
with tissue of expected infectivity (group 3, study 2) because there was no
significant difference for any of the signs.
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controls. Similar observations have been made in a sepa-
rate study in casualty slaughtered cattle [31].
The design, particularly group sizes, of the source stu-
dies presented difficulty in analysing the clinical signs with
regards to the choice of statistical tests. Two different
methods were chosen to compare the frequency of
expressed clinical signs, either taking into account
repeated observations or using only the last assessment
prior to cull. BSE is a slowly progressive disease and signs
are displayed more frequently, more consistently and
more severely as the disease progresses, which makes Cox
regression survival analysis an appropriate method. How-
ever, in study 1 cattle were culled at a predetermined time
point post challenge or, in both studies, at a predeter-
mined end point when the development of BSE was not
expected in surviving animals. Therefore, some of the ani-
mals may have been at an early stage of the disease when
signs associated with BSE were observed only shortly
before culling and not yet repeatedly. In these cases, the
Fisher’s exact test was more applicable, which only consid-
ered the occurrence of a sign prior to cull. Regardless of
the statistical method, the results confirmed, as expected,
that the selected signs associated with BSE occurred more
frequently in groups with diagnostic changes of vacuola-
tion and/or PrP
d accumulation.
The histopathological diagnosis based on vacuolar
changes is less sensitive than detection of PrP
d by IHC,
Table 6 Relative frequency of clinical signs at observations over time post inoculation compared to control cattle
Study 1 1 1 1 2 2 2
Groups 100 g 1 g 1 g 100 g 4 3 2
Postmortem BSE diagnosis Pos Pos Neg Neg Pos Neg Neg
Behaviour
Flank licking ↑↑↑ ↑↑ ↓↓↓ ↓↓↓ ↓↓↓
Unusual asymmetrical ear movements ↑↑↑ ↑↑
Vocalisation ↑↑
Head toss ↑↑
Snorting ↑↑ ↓↓↓
Nose licking ↑↑ ↓↓↓
Grooming self ↑↑ ↑↑
Apprehension ↑↑ ↑↑↑
BSE series of events ↓↓↓ ↑↑ ↑
Grooming others ↑↑ ↑↑
Standing idle & not approached ↓↓↓ ↓↓↓ ↑↑↑
Mounting ↑↑ ↑↑↑ ↑↑ ↑↑↑
Sneezing ↑↑
Being mounted ↑
Head rubbing ↓↓↓
Nose wrinkling ↓↓↓
Coughing ↓↓↓
Sensation
Startle at movement including hand approach/clipboard test ↑↑↑ ↑↑↑ ↑↑↑
Hyperaesthesia ↑↑↑ ↓↓ ↑↑↑
Startle at movement ↑↑↑ ↑ ↑↑↑ ↑↑↑
Startle at noise ↑↑ ↑↑↑
Abnormal hand approach/clipboard test ↑↑
Movement and posture
Muscle fasciculations ↑↑ ↑↑↑ ↑↑
Tremor ↑↑
Abnormal head carriage ↓
Groups were compared with undosed controls (study 1) and saline-inoculated controls (study 2).
↑= greater/↓ = lower hazard rate than controls, with P<0.001 (three arrows), P = 0.001-0.01 (two arrows) and P>0.01 and <0.0125 (four comparisons) or <0.0167
(three comparisons) (one arrow). Blank cell: no significant difference.
Only signs that were significantly differently displayed compared to controls are listed.
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[13,18,32], since, in general, histopathological changes
are apparent later in the course of the disease than
detection of PrP
d. The more frequent occurrence of
locomotor and sensory signs in cattle with vacuolar
changes compared to those with no or equivocal vacuo-
lation (Table 2) suggests that vacuolation coincides with
a more advanced clinical stage. This is in agreement
with the findings in a Swiss study, where clinical suspect
BSE cases had more severe spongiform changes in the
brain than BSE cases slaughtered as apparently healthy
cattle [33].
The great variation in the group sizes meant that for
some signs statistical analysis was compromised because
the number of animals per group was too small. It was
considered appropriate to combine BSE-positive animals
dosed with 1 g and 100 g to increase the sample size for
comparison of signs prior to cull although this was less
appropriate for the analysis of signs over time, which
may be dependent on the dose. It has been demon-
strated in cattle orally challenged with BSE that the
incubation period followed a lognormal distribution,
with decreasing mean as dose increased [13], and thus a
similar effect of dose on onset of the first clinical signs
and possibly the disease duration is expected. In study 2
in particular, the number of animals in some groups
was considerably greater than in others, ranging from 10
to 240. As a result of the disproportionate group sizes,
the differences in the signs displayed by BSE-negative
cattle inoculated with tissue sf r o mc a t t l eo r a l l yd o s e d
with BSE-affected brain and controls were usually not
significant, or signs were even less frequently observed
over a time period than in controls. In these instances,
comparison of signs on a case-to-case basis may be
more appropriate, like the selection of clinical markers
to identify clinical suspects as demonstrated in Table 1.
Although the signs used for comparison of the differ-
ent groups of cattle in different source studies consisted
of behavioural, sensory and locomotor signs associated
with BSE [3,24,25], many of these signs are unspecific,
or not characteristic of a neurological disease and may
also be displayed to some degree in healthy cattle. This
m a ye x p l a i nw h ys o m eo ft h es i g n sw e r em o r ef r e q u e n t
in BSE-positive cattle of one study but not in the other.
For example, “BSE series of events”, which were defined
as behavioural signs in combination with head tossing
or nose licking, all of which were associated with BSE
[25], were usually significa n t l ym o r ef r e q u e n ti nB S E - -
positive cattle of study 2 but were unexpectedly signifi-
cantly less frequent in BSE-positive cattle dosed with 1
g compared to controls of study 1. Other signs that
may be neurogenic, such as tremor, may occur physio-
logically in anxious animals or may be displayed as
hind limb tremor in animals with spastic syndrome,
which occurred in some animals but was not consid-
ered to be associated with BSE (data not shown). To
simplify the analysis, the absence or presence of tre-
mor was assessed regardless of location and underlying
condition. In most cases, in particular when the tremor
was not confined to the head, it was impossible to
determine the cause based on a clinical examination
and to differentiate a potential physiological tremor or
a tremor caused by other intercurrent diseases from an
identical tremor displayed by BSE-affected cattle.
Furthermore, the finding that significant differences
were not consistently present between BSE-positive
cattle and controls, for example in the display of ner-
vousness on head tests or head restraint, made it diffi-
cult to interpret the significance of these signs. This
m a yb ep a r t l ye x p l a i n e db yt h ed i f f e r e n tt r e a t m e n to f
animals between studies, such as regular blood sam-
pling, which was done only in cattle of study 1. We
also cannot rule out that the route of inoculation (oral
or intracerebral) has an effect on the display of parti-
cular signs since the route of infection may result in
minor differences in the severity of vacuolar changes
[32,34,35] although cattle with BSE have generally pre-
sented with changes in behaviour, sensation and loco-
motion irrespective of the route [32,36].
A predominant sign of BSE is over-reactivity to exter-
nal stimuli, which has been observed in 75-98% of con-
firmed clinical field cases [30]. Its presence was so
characteristic in BSE that tests of over-reactivity have
been refined successfully to diagnose BSE [24], to pre-
dict cases among BSE suspects prior to postmortem test
confirmation [5] and to screen casualty slaughter cattle
for BSE [31]. Startle responses are also observed fre-
quently in patients suffering from sporadic Creutzfeldt-
Jakob disease [37,38]. Indeed, startle responses to tests
of over-reactivity and apparently spontaneous startle,
occurring during examinations or observed on weekly
observations, were consistently more frequent in BSE-
positive animals compared to controls and this was
often statistically significant. Interestingly, the repeated
display of startle responses was also significantly more
frequent in cattle orally dosed with 1 g and 100 g of
BSE brainstem in study 1 despite a negative postmortem
test result, regardless of the statistical method used.
Similarly, cattle inoculated with tissue from BSE-
challenged cattle (study 2, group 3) startled to the
observer’s movement significantly more often than con-
trol cattle when signs over time were compared. Ner-
vousness or apprehension in the corridor and tremor
were also significantly more frequently displayed in
BSE-negative cattle orally dosed with 100 g using the
Cox regression analysis. In the absence of histopatholo-
gical changes in the brains of these cattle and the exclu-
sion of metabolic diseases by regular blood biochemical
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it is possible that the signs were actually caused by BSE.
There are some precedents for this in other species,
such as mice [39] and pigs [40] inoculated with the BSE
agent and goats naturally infected with scrapie [41],
which presented with signs suggestive of a TSE despite
failure to detect PrP
d in the brain. In a previous study,
of the animals in the present study 1, which sought to
predict the relationship between detection of PrP
d and
incubation period according to dose, the clinical criteria
were based on the combination of clinical signs consis-
tent with the “definite” clinical diagnosis of BSE which
was considered equivalent to reporting of the animal as
a suspect in the field [13]. This approach includes the
use of classifications of possible and probable signs of
BSE [7] where “possible” and “probable” indicate a
potential earlier clinical stage based on the relative fre-
quency and severity of signs or sign combinations.
Using this approach, it has been shown that some ani-
mals in both of the present studies may display possible
or probable signs in the absence of a positive postmor-
tem test result [14,21].
Improvement of postmortem test protocols over time
has accounted for increased sensitivity of the diagnosis
of BSE cases in an experimental oral exposure cattle
study [13,42]. Also, studies utilising brain tissue from
selected orally dosed, postmortem test unconfirmed cat-
tle in study 1, have demonstrated the presence of infec-
tivity by assay in transgenic mice overexpressing bovine
PrP [26] and the presence of PrP
res by PMCA [43].
There are therefore clear precedents for the prudent
application of additional transmissibility, molecular and
neuropathological assessments of clinically healthy ani-
mals inoculated with a TSE agent to exclude the possi-
bility of subclinical prion infection, which has been
often demonstrated in rodent studies [44]. The possible
occurrence of clinical disease in cattle unconfirmed by
current postmortem tests equally warrants further
investigation.
Conclusions
Selected signs associated with BSE were more frequently
displayed in pathologically confirmed experimental BSE
cases compared to un-inoculated controls and, among
confirmed cases, signs were more frequently expressed
in cases with vacuolar pathology, indicative of a more
advanced stage of disease. However, certain behavioural
and sensory signs associated with BSE or a combination
of behavioural, sensory or locomotor signs suggestive of
BSE were also found more frequently in BSE inoculated
cattle that were not confirmed by postmortem examina-
tions. It is suggested that the additional techniques of
tissue bioassay in transgenic mice overexpressing bovine
PrP and PMCA are required to determine the possible
significance of this apparent insensitivity of the diagnos-
tic postmortem examinations.
Additional material
Additional file 1: Assessed signs. Clinical signs used for comparison
and definition of the sign.
Additional file 2: CN1150 (suspect-BSE positive). Steer, examined
prior to cull at 47 months after intracerebral inoculation with a pool of
palatine tonsil collected from cattle orally exposed to BSE affected
brainstem and killed 10 mpi. The steer does not over-react to testing of
facial sensation although it retracts its head in the yoke of the crush and
later becomes agitated. A mild spontaneous startle occurs during
locomotion after the steer crosses the hose on the floor. Ataxia is
evident when it jumps over the hose and approaches its pen mates
(released into the corridor because of the steer’s reluctance to walk).
Note the steer’s apprehension when close to the camera at the end of
the clip. It also shows poor bodily condition. This steer was positive for
BSE by postmortem tests with vacuolar changes in the obex.
Additional file 3: CP1503 (suspect-BSE negative). Steer, examined
prior to cull at 87 months after intracerebral inoculation with a pool of
spleens collected from cattle orally exposed to BSE affected brainstem
and killed 18 mpi (study 2). This steer is slightly over-reactive to cranial
nerve testing. It also over-reacts to touch on the neck (recorded as
“nervous on neck prick”). It does not over-react to sudden flash light but
a head tremor is evident during the procedure. The steer displays
marked hind limb hypermetria, which is most pronounced as it reaches
the end of the corridor. The steer also appears apprehensive in the
corridor, as indicated by hesitation in passing the examiner and a very
alert facial expression with ear movements when close to the camera.
Note also the head and neck tremor when the animal stands near the
camera at the end of the clip. This steer was negative for BSE by
postmortem tests. Histopathologically, there was no evidence of a
cerebellar lesion which may have produced hypermetria and head
tremor.
Additional file 4: 143 (BSE positive-IHC). Steer, examined prior to cull
at 42 months after oral dosing with 100 g of BSE affected brainstem
homogenate (study 1). This steer does not over-react to cranial nerve
testing but repeatedly startles at a sudden metallic sound (recorded as
“repeated over-reactivity to sound”). It appears apprehensive in the
corridor, circles on the spot and startles when it is encouraged to move
away from the gate by hand clapping. The histopathological diagnosis
was inconclusive for BSE (minimal vacuolation in the obex) but BSE was
confirmed by other postmortem tests.
Additional file 5: 139 (BSE positive-HP). Steer, examined prior to cull
at 39 months after oral dosing with 100 g of BSE affected brainstem
homogenate (study 1). This steer is apprehensive in the corridor and very
reluctant to approach the crush, seemingly afraid of the channel and
later the wet patch on the floor. Note the spontaneous startle while
approaching the crush. Its reaction to menace response testing is
exaggerated and it over-reacts to facial stimuli with repeated rapid,
forceful upwards head movements (head bobbing, recorded as ‘nervous
on head tests’). Exposure to a flash of light elicits startle, even on
repeated tests. This steer was positive for BSE by postmortem tests with
vacuolar changes in the obex.
Additional file 6: 10 (control). Undosed control steer, examined prior
to cull at 45 months of age. It over-reacts to facial stimuli, but not
menace response testing. The head tossing activity does not resemble
the head bobbing movements of steer 139. During locomotion the steer
appears calm and stops to explore various objects along its path. This
steer was negative for BSE by postmortem tests.
Additional file 7: 138 (BSE negative-HP&IHC). Steer, examined prior to
cull at 42 months after oral dosing with 100 g of BSE brainstem
homogenate (study 1). The steer’s behaviour during cranial nerve testing
is unremarkable. It appears apprehensive in the corridor, particularly on
approaching the channel and drain and the hose across the floor.
Trembling of the rump muscles is visible from behind when the animal
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Page 11 of 13stops in front of the channel before crossing it. Note also the mild startle
when the examiner walks in front of the steer whilst it is exploring the
channel. This steer was negative for BSE by postmortem tests upon
examination of the brain. In a separate study, PrP
d was found in the
lymphoid follicles of the ileum of this steer, which suggests that it was
infected with the BSE agent (GAH Wells and M Stack, unpublished
observation).
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